Environmental enrichment and gene-environment interactions in mouse models of brain disorders

Neuromethods

Volumn 44, Issue , 2010, Pages 201-216

  Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Gene environment interactions; Huntington's disease; Knockout mice; Mental activity; Physical exercise; Rett syndrome; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; FLUOXETINE; NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; AUTISM; BRAIN CORTEX; BRAIN DISEASE; BRAIN DYSFUNCTION; CHOREA; CHROMOSOME 21; COGNITIVE DEFECT; CONSTRUCT VALIDITY; DEGENERATIVE DISEASE; DEPRESSION; DEVELOPMENTAL DISORDER; DOWN SYNDROME; ENVIRONMENTAL ENRICHMENT; ENVIRONMENTAL FACTOR; FRAGILE X SYNDROME; GENE ENVIRONMENT INTERACTION; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENETIC PREDISPOSITION; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEARNING DISORDER; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; MUTANT; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PHYSICAL ACTIVITY; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; RISK; SCHIZOPHRENIA; STRESS; SYNAPTOGENESIS; TRANSGENIC MOUSE; UPREGULATION;

MUS; MUS MUSCULUS;

EID: 73849142340     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-474-6_11     Document Type: Review

References (66)

1. Nithianantharajah J, Hannan AJ (2006) Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 7:697-709
2. Van Praag H, Kempermann G, Gage FH (2000) Neural consequences of environmental enrichment. Nat Rev Neurosci 1:191-198
3. Grote HE, Hannan AJ (2007) Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol 34:533-545
4. Laviola G, Hannan AJ, Macri S, Solinas M, Jaber M (2008) Effects of enriched environment on animal models of neurodegenerative and psychiatric disorders. Neurobiol Dis 31:159-168
5. Nithianantharajah J, Hannan AJ (2007) Dynamic mutations as digital genetic modulators of brain development, function and dysfunction. Bioessays 29:525-535
6. Bates G, Harper PS, Jones L (eds) (2002) Huntington's disease, 3rd edn. Oxford University Press, Oxford, England
7. Feigen VL, Bennett DA (2007) Handbook of clinical neuroepidemiology. Nova Science Publishers, New York, USA
8. Van Dellen A, Blakemore C, Deacon R et al (2000) Delaying the onset of Huntington's in mice. Nature 404:721-722
9. Hockly E, Cordery P, Woodman B et al (2002) Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol 51:235-242
10. Spires TL, Grote HE, Varshney NK et al (2004) EE rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 24:2270-2276
11. Spires TL, Grote HE, Garry S et al (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci 19:2799-2807
12. Glass M, Van Dellen A, Blakemore C et al (2004) Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123:207-212
13. Schilling G et al (2004) Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol 187:137-149
14. Nithianantharajah AJ, Barkus C, Murphy M, Hannan AJ (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis 29:490-504
15. Pang TYC, Du X, Zajac MS et al (2009) Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet 18:753-766
16. Lazic SE, Grote H, Armstrong RJ et al (2004) Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport 15:811-813
17. Grote HE, Bull ND, Howard ML et al (2005) Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081-2088
18. Pang TY, Stam NC, Nithianantharajah J et al (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 141:569-584
19. Lazic SE, Grote HE, Blakemore C et al (2006) Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur J Neurosci 23:1829-1838
20. Nithianantharajah J, Vijiaratnam N, Barkus C, et al (2009) Modeling brain reserve: experience- dependent neuronal plasticity in healthy and Huntington's disease transgenic mice. Am J Ger Psychiatry 17:196-209
21. Van Dellen A, Cordery PM, Spires TL et al (2008) Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disesase. BMC Neurosci 9:34
22. Wexler NS, Lorimer J, Porter J et al (2004) U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA 101:3498-3503
23. Masters CL, Cappai R, Barnham KJ, Villemagne VL (2006) Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J Neurochem 97:1700-1725 (Pubitemid 43873662)
24. Levi O, Jongen-Relo AL, Feldon J et al (2003) ApoE4 impairs hippocampal plasticity isoform- specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis 13:273-282
25. Jankowsky JL, Xu G, Fromholt D et al (2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62:1220-1227
26. Arendash GW, Garcia MF, Costa DA et al (2004) Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15:1751-1754
27. Jankowsky JL, Melnikova T, Fadale DJ et al (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25:5217-5224
28. Lazarov O, Robinson J, Tang YP et al (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701-713
29. Spires TL, Hannan AJ (2007) Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease. J Neurochem 100:874-882
30. Feng R et al (2001) Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 32:911-926
31. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25:4217-4221
32. Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81-104
33. Spires TL, Hannan AJ (2005) Nature, nurture and neurology: gene-environment interactions in neurodegeneration. FEBS J 272:2347-2361
34. Valenzuela MJ, Sachdev P (2006) Brain reserve and dementia: a systematic review. Psychol Med 36:441-454
35. Turner BJ, Talbot K (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol 85:94-134
36. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT (2003) Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 53:804-807
37. Veldink JH et al (2003) Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 13:737-743
38. Mahoney DJ, Rodriguez C, Devries M et al (2004) Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29:656-662
39. Kaspar BK, Frost LM, Christian L et al (2005) Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 57:649-655
40. Liebetanz D, Hagemann K, Von Lewinski F et al (2004) Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 20:3115-3120
41. Stam N, Nithianantharajah J, Howard ML et al (2008) Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 28:717-723
42. Williamson SL, Christodoulou J (2006) Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 14:896-903
43. Amir RE, Van Den Veyver IB, Wan M et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet 23:185-188
44. Bienvenu T, Chelly J (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7:415-426
45. Guy J, Gan J, Selfridge J et al (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143-1147
46. Giacometti E, Luikenhuis S, Beard C, Jaenisch R (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104:1931-1936
47. Pelka GJ, Watson CM, Radziewic T et al (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129:887-898
48. Kondo M, Gray L, Pelka GJ, Christodoulou J, Tam PPL, Hannan AJ (2008) Motor deficits in a Rett syndrome mouse model are ameliorated by environmental enrichment. Eur J Neurosci 27:3342-3350
49. Nag N, Moriuchi JM, Peitzman CG et al (2009) Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice. Behav Brain Res 196:44-48
50. Fondon JW, Hammock EAD, Hannan AJ, King DJ (2008) Simple sequence repeats: genetic modulators of brain function and behavior. Trends Neurosci 31:328-334
51. Restivo L, Ferrari F, Passino E et al (2005) Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc Natl Acad Sci USA 102:11557-11562
52. Martinez-Cue C, Baamonde C, Lumbreras M et al (2002) Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. Behav Brain Res 134:185-200
53. Dierssen M, Benavides-Piccione R, Martinez- Cue C et al (2003) Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of EE. Cereb Cortex 13:758-764
54. Martinez-Cue C, Rueda N, Garcia E et al (2005) Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome. Behav Brain Res 163:174-185
55. Wood SJ, Pantelis C, Velakoulis D et al (2008) Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull 34:322-329
56. O'Tuathaigh CM, Babovic D, O'Meara G et al (2007) Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. Neurosci Biobehav Rev 31:60-78
57. Hannan AJ, Blakemore C, Katsnelson A et al (2001) PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat Neurosci 4:282-288
58. Spires TL, Molnar Z et al (2005) Activitydependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-beta1 signalling. Cereb Cortex 15:385-393
59. McOmish CE, Burrows E, Howard M, Hannan AJ (2008) PLC-1 knockout mice as a model of disrupted cortical development and plasticity: behavioral endophenotypes and dysregulation of RGS4 gene expression. Hippocampus 18:824-834
60. Gray L, McOmish CE, Scarr E et al (2009) Sensitivity to MK-801 in phospholipase C-1 knockout mice reveals a specific NMDA receptor deficit. Int J Neuropsychopharmacol 12:917-928
61. McOmish CE, Burrows E, Howard M et al (2007) Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol Psychiatry 13:661-672
62. Caspi A, Sugden K, Moffitt TE, Taylor A et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389
63. Francis DD, Diorio J, Plotsky PM, Meaney MJ (2002) EE reverses the effects of maternal separation on stress reactivity. J Neurosci 22:7840-7843
64. Kalueff AV, Wheaton M, Murphy DL (2007) What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res 179:1-18
65. Hannan AJ (2004) Huntington's disease: which drugs might help patients? IDrugs 7:351-358
66. McOmish CE, Hannan AJ (2007) Enviromimetics: exploring gene-environment interactions to identify therapeutic targets for brain disorders. Expert Opin Ther Targets 11:899-913